Amicus Therapeutics
FOLD
FOLD was delisted on the 24th of April, 2026.
125 hedge funds and large institutions have $892M invested in Amicus Therapeutics in 2015 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 22 closing their positions.
73% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 22
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
35% more capital invested
Capital invested by funds: $662M → $892M (+$231M)
24% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 33
15% more funds holding
Funds holding: 109 → 125 (+16)
4% less call options, than puts
Call options by funds: $12.4M | Put options by funds: $12.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$13.8M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$12.2M |
| 3 |
Millennium Management
New York
|
+$6.44M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$6.19M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$6.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$47M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$9.19M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$5.82M |
| 4 |
D.E. Shaw & Co
New York
|
-$4.29M |
| 5 |
Renaissance Technologies
New York
|
-$4.23M |
FOLD Hedge Fund Activity: Q1 2015 in Review
125 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q1 2015, worth a combined $892M — up 35% from $662M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new FOLD positions and 22 closed out — a net gain of 16 holders — while 41 added to existing stakes and 33 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $13.8M. The largest seller was NEA Management Company, exiting entirely with an estimated $47M sold.
- 125 institutional investors held Amicus Therapeutics (FOLD) as of Q1 2015, up from 109 in Q4 2014.
- Funds reported $892M of Amicus Therapeutics stock for Q1 2015, up 35% quarter-over-quarter.
- 38 funds opened new Amicus Therapeutics positions in Q1 2015 and 22 closed out, a net change of +16 holders.
- The largest Amicus Therapeutics buyer in Q1 2015 was Citadel Advisors, an estimated $13.8M added.
- The largest Amicus Therapeutics seller in Q1 2015 was NEA Management Company, an estimated $47M sold.
Based on aggregated 13F filings for Q1 2015.